| [1] |
Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells[J]. Nature, 2012, 489(7414): 101-108.
|
| [2] |
Devaux Y, Zangrando J, Schroen B, et al. Long noncoding RNAs in cardiac development and ageing[J]. Nat Rev Cardiol, 2015, 12(7): 415-425.
|
| [3] |
Hall LL, Lawrence JB. XIST RNA and architecture of the inactive X chromosome: implications for the repeat genome[J]. Cold Spring Harb Symp Quant Biol, 2010, 75: 345-356.
|
| [4] |
Jégu T, Aeby E, Lee JT. The X chromosome in space[J]. Nat Rev Genet, 2017, 18(6): 377-389.
|
| [5] |
Zhang LF, Huynh KD, Lee JT. Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing[J]. Cell, 2007, 129(4): 693-706.
|
| [6] |
Zhu Y, Hu H, Yuan Z, et al. LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness[J]. Cell Death Dis, 2020, 11(11): 962.
|
| [7] |
Zhao J, Sun BK, Erwin JA, et al. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome[J]. Science, 2008, 322(5902): 750-756.
|
| [8] |
Jain AK, Xi Y, McCarthy R, et al. LncPRESS1 is a p53-Regulated LncRNA that safeguards pluripotency by disrupting SIRT6-mediated de-acetylation of histone H3K56[J]. Mol Cell, 2016, 64(5): 967-981.
|
| [9] |
He W, Zhong G, Jiang N. et al. Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis[J]. J Clin Invest, 2018, 128(2): 861-875.
|
| [10] |
Tian T, Lv X, Pan G, et al. Long noncoding RNA MPRL promotes mitochondrial fission and cisplatin chemosensitivity via disruption of pre-miRNA processing[J]. Clin Cancer Res, 2019, 25(12): 3673-3688.
|
| [11] |
Lu C, Wei Y, Wang X. et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma[J]. Mol Cancer, 2020, 19(1): 28.
|
| [12] |
Yuan JH, Liu XN, Wang TT. et al. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1[J]. Nat Cell Biol, 2017, 19(7): 820-832.
|
| [13] |
Jain AK, Xi Y, McCarthy R, et al. LncPRESS1 is a p53-Regulated lncRNA that safeguards pluripotency by disrupting SIRT6-mediated de-acetylation of histone H3K56[J]. Mol Cell, 2016, 64(5): 967-981.
|
| [14] |
Liu B, Sun L, Liu Q, et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis[J]. Cancer Cell, 2015, 27(3): 370-381.
|
| [15] |
Huang JZ, Chen M, Chen D, et al. A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth[J]. Mol Cell, 2017, 68(1): 171-184, e6.
|
| [16] |
Zhang M, Weng W, Zhang Q, et al. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5[J]. J Hematol Oncol, 2018, 11(1): 113.
|
| [17] |
Cheng X, Xu X, Chen D, et al. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer[J]. Biomed Pharmacother, 2019, 110: 473-481.
|
| [18] |
Luo Y, Chen JJ, Lv Q, et al. Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/β-catenin signaling pathway[J]. Cancer Lett, 2019, 440-441: 11-22.
|
| [19] |
Peng W, Wang Z, Fan H. LncRNA NEAT1 impacts cell proliferation and apoptosis of colorectal cancer via regulation of Akt signaling[J]. Pathol Oncol Res, 2017, 23(3): 651-656.
|
| [20] |
Yang MH, Zhao L, Wang L, et al. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin-β3 transcriptional activating and MAPK/AKT signalling[J]. Mol Cancer, 2019, 18(1): 31.
|
| [21] |
Ghasemi F, Shafiee M, Banikazemi Z, et al. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells[J]. Pathol Res Practice, 2019, 215: 152556.
|
| [22] |
Zhong ME, Chen Y, Zhang G, et al. LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network[J]. Cancer Cell Int, 2019, 19: 148.
|
| [23] |
Sun C, Ma P, Wang Y, et al. KLF15 inhibits cell proliferation in gastric cancer cells via up-regulating CDKN1A/p21 and CDKN1C/p57 expression[J]. Dig Dis Sci, 2017, 62(6): 1518-1526.
|
| [24] |
Bykov VJN, Eriksson SE, Bianchi J, et al. Targeting mutant p53 for efficient cancer therapy[J]. Nat Rev Cancer, 2018, 18(2): 89-102.
|
| [25] |
Hientz K, Mohr A, Bhakta-Guha D, et al. The role of p53 in cancer drug resistance and targeted chemotherapy[J]. Oncotarget, 2017, 8(5): 8921-8946.
|
| [26] |
Thorenoor N, Faltejskova-Vychytilova P, Hombach S, et al. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer[J]. Oncotarget, 2016, 7(1): 622-637.
|
| [27] |
Liu F, Wang X, Liu H, et al. LncRNA BX357664 inhibits cell proliferation and invasion and promotes cell apoptosis in human colorectal cancer cells[J]. Oncol Lett, 2018, 15(6): 8237-8244.
|
| [28] |
Cui C, Zhai D, Cai L, et al. Long noncoding RNA HEIH promotes colorectal cancer tumorigenesis via counteracting miR-939‒mediated transcriptional repression of Bcl-xL[J]. Cancer Res Treat, 2018, 50(3): 992-1008.
|
| [29] |
Zhang W, Yuan W, Song J, et al. LncRna CPS1-IT1 suppresses cell proliferation, invasion and metastasis in colorectal cancer[J]. Cell Physiol Biochem, 2017, 44(2): 567-580.
|
| [30] |
Xue J, Liao L, Yin F, et al. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway[J]. Cancer Biomark, 2018, 21(4): 849-858.
|
| [31] |
Zhang H, Song Y, Yang C, et al. Overexpression of lncRNA TUSC7 reduces cell migration and invasion in colorectal cancer[J]. Oncol Rep, 2019, 41(6): 3386-3392.
|
| [32] |
Márquez-Jurado S, Díaz-Colunga J, das Neves RP, et al. Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression[J]. Nat Commun, 2018, 9(1): 389.
|
| [33] |
Stintzing S, Modest DP, Rossius L, et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial[J]. The Lancet Oncology, 2016, 17(10): 1426-1434.
|
| [34] |
Longley DB, Allen WL, Johnston PG. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer[J]. Biochim Biophys Acta, 2006, 1766(2): 184-196.
|
| [35] |
Wang M, Han D, Yuan Z, et al. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy[J]. Cell Death Dis, 2018, 9(12): 1149.
|
| [36] |
Jiang X, Li Q, Zhang S, et al. Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer[J]. Onco Targets Ther, 2019, 12: 1059-1070.
|
| [37] |
Dobreva G, Chahrour M, Dautzenberg M, et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation[J]. Cell, 2006, 125(5): 971-986.
|
| [38] |
Xu M, Xu X, Pan B, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2[J]. Mol Cancer, 2019, 18: 1-16.
|
| [39] |
Tang L, Li Q, Ge X, et al. LncRNA GAS5 inhibits progression of colorectal cancer by regulating M1/M2 macrophages polarization. AIP Conference Proceedings[J]. AIP Conference Proceedings, 2019, 2110(1): 020013.
|
| [40] |
Yu X, Yuan Z, Yang Z, et al. The novel long noncoding RNA u50535 promotes colorectal cancer growth and metastasis by regulating CCL20[J]. Cell Death Dis, 2018, 9(7): 751.
|
| [41] |
Liang ZX, Liu HS, Wang FW, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J]. Cell Death Dis, 2019, (10): 1-17.
|
| [42] |
Zhao W, Song M, Zhang J, et al. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma[J]. Int J Clin Exp Pathol, 2015, 8(11): 14131-14140.
|
| [43] |
Wan L, Kong J, Tang J, et al. HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor[J]. J Cell Mol Med, 2016, (20): 2036-2044.
|
| [44] |
Ouyang W, Ren L, Liu G, et al. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer[J]. Peer J, 2019, 7: e6683.
|